X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (22) 22
humans (20) 20
pharmacology & pharmacy (12) 12
male (11) 11
adult (9) 9
apixaban (9) 9
female (9) 9
pharmacokinetics (9) 9
middle aged (7) 7
administration, oral (6) 6
chemistry, analytical (6) 6
factor xa inhibitor (6) 6
pharmacodynamics (6) 6
pyrazoles - pharmacokinetics (6) 6
pyridones - pharmacokinetics (6) 6
analysis (5) 5
animals (5) 5
area under curve (5) 5
chromatography, high pressure liquid - methods (5) 5
pyrazoles - adverse effects (5) 5
pyrazoles - pharmacology (5) 5
pyridones - adverse effects (5) 5
pyridones - pharmacology (5) 5
reproducibility of results (5) 5
research (5) 5
safety (5) 5
advances and applications [clinical pharmacology] (4) 4
dosage and administration (4) 4
dose-response relationship, drug (4) 4
international normalized ratio (4) 4
sensitivity and specificity (4) 4
therapeutics. pharmacology (4) 4
thromboprophylaxis (4) 4
aged (3) 3
alanine - analogs & derivatives (3) 3
anticoagulants (3) 3
biochemical research methods (3) 3
bms-540215 (3) 3
drug interactions (3) 3
drug therapy (3) 3
enoxaparin (3) 3
factor xa inhibitors (3) 3
factor xa inhibitors - blood (3) 3
factor xa inhibitors - pharmacokinetics (3) 3
growth-factor receptor-2 (3) 3
human plasma (3) 3
laboratories (3) 3
lc/ms/ms (3) 3
mass spectrometry (3) 3
neoplasms - drug therapy (3) 3
original research (3) 3
prothrombin time (3) 3
pyrazoles - blood (3) 3
pyridones - blood (3) 3
rats (3) 3
rats, sprague-dawley (3) 3
rivaroxaban (3) 3
safety and security measures (3) 3
spectrometry, mass, electrospray ionization - methods (3) 3
tandem mass spectrometry - methods (3) 3
thromboembolism (3) 3
triazines - pharmacokinetics (3) 3
venous thromboembolism (3) 3
adolescent (2) 2
alanine - pharmacokinetics (2) 2
angiogenesis (2) 2
anticoagulant (2) 2
anticoagulants - adverse effects (2) 2
anticoagulants - pharmacokinetics (2) 2
anticoagulation (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic agents - pharmacokinetics (2) 2
antineoplastic agents - urine (2) 2
atrial-fibrillation (2) 2
bioavailability (2) 2
biological-fluids (2) 2
blood (2) 2
cancer (2) 2
care and treatment (2) 2
chromatography, liquid - methods (2) 2
chronic kidney failure (2) 2
discovery (2) 2
dogs (2) 2
drug stability (2) 2
factor (2) 2
factor xa - analysis (2) 2
factor xa inhibitors - adverse effects (2) 2
factor xa inhibitors - pharmacology (2) 2
genetic aspects (2) 2
genetics & heredity (2) 2
health aspects (2) 2
healthy-subjects (2) 2
hypoglycemic agents - blood (2) 2
in-vitro (2) 2
indoles - blood (2) 2
indoles - pharmacokinetics (2) 2
injection (2) 2
japanese (2) 2
knee replacement (2) 2
lc-ms/ms (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Pharmacology: Advances and Applications, ISSN 1179-1438, 11/2014, Volume 6, pp. 179 - 187
Currently, there are no direct comparisons of apixaban and rivaroxaban, two new oral direct factor Xa inhibitors approved for management of thromboembolic... 
Rivaroxaban | Pharmacodynamics | Safety | Pharmacokinetics | Apixaban | Dosage and administration | Research | Thromboembolism | Drug therapy | Prevention | Laboratories | Surgery | Scientific imaging | Joint surgery | Bioavailability | Mass spectrometry
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2016, Volume 56, Issue 5, pp. 648 - 649
Journal Article
Clinical Pharmacology: Advances and Applications, ISSN 1179-1438, 04/2013, Volume 5, pp. 59 - 66
Apixaban is an oral, selective, direct factor Xa inhibitor approved for thromboprophylaxis after orthopedic surgery and stroke prevention in patients with... 
Famotidine | Drug-drug interaction | hOCT inhibitor | receptor antagonists | Apixaban | Factor Xa inhibitor | Research | Pharmacokinetics | Thromboembolism | Drug therapy | Health aspects | Bone surgery | Stroke
Journal Article
Journal Article
Genome Medicine, ISSN 1756-994X, 09/2017, Volume 9, Issue 1, pp. 83 - 83
Journal Article
Clinical pharmacology : advances and applications, ISSN 1179-1438, 2018, Volume 10, pp. 153 - 163
This double-blind, placebo-controlled, intra-subject, dose-escalation study assessed single-dose safety, pharmacokinetics, and pharmacodynamics of apixaban in... 
Urine | Plasma | Cardiac arrhythmia | Anticoagulants | Ethnicity | Laboratories | Population | Influence | Bioavailability | Thromboembolism | Drug dosages | safety | pharmacodynamics | Eliquis | anticoagulation | pharmacokinetics | Japanese | apixaban | Asian | novel
Journal Article
Clinical Pharmacology: Advances and Applications, ISSN 1179-1438, 01/2018, Volume 10, pp. 71 - 72
Frost C, Song Y, Barrett YC, et al. Clin Pharmacol. 2014;6:179-187.Page 183, Figure 2, the arithmetic mean apixaban trough concentration on Day 4 prior to the... 
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 03/2015, Volume 107, pp. 409 - 418
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 05/2012, Volume 107, Issue 5, pp. 916 - 924
Following major orthopaedic surgery, guidelines usually recommend continued thromboprophylaxis after hospitalisation. The availability of an effective oral... 
drug switching | thromboprophylaxis | Factor Xa inhibitor | pharmacokinetics/pharmacodynamics | Apixaban | Blood Coagulation, Fibrinolysis and Cellular Haemostasis | Thromboprophylaxis | Factor xa inhibitor | Pharmacokinetics/phar-macodynamics | Drug switching | RIVAROXABAN | PREVENTION | TOTAL KNEE ARTHROPLASTY | TRIAL | VENOUS THROMBOEMBOLISM | DABIGATRAN ETEXILATE | DOUBLE-BLIND | TOTAL HIP-REPLACEMENT | PERIPHERAL VASCULAR DISEASE | factor Xa inhibitor | HEMATOLOGY | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Middle Aged | Prothrombin Time | Male | Enoxaparin - adverse effects | Fibrinolytic Agents - adverse effects | Pyridones - administration & dosage | Enoxaparin - administration & dosage | Drug Interactions | Fibrinolytic Agents - pharmacokinetics | Injections, Subcutaneous | Adult | Female | Pyrazoles - pharmacokinetics | Pyrazoles - adverse effects | Drug Administration Schedule | Pyridones - pharmacokinetics | Administration, Oral | Anticoagulants - adverse effects | Factor Xa - metabolism | New Jersey | Cross-Over Studies | International Normalized Ratio | Pyrazoles - administration & dosage | Blood Coagulation - drug effects | Partial Thromboplastin Time | Anticoagulants - pharmacokinetics | Fibrinolytic Agents - administration & dosage | Drug Substitution | Pyridones - adverse effects
Journal Article
Journal Article
Clinical Pharmacology: Advances and Applications, ISSN 1179-1438, 01/2018, Volume 10, p. 153
Journal Article
Clinical pharmacology : advances and applications, ISSN 1179-1438, 2018, Volume 10, pp. 71 - 71
[This corrects the article on p. 179 in vol. 6, PMID: 25419161.]. 
Journal Article
Prenatal Diagnosis, ISSN 0197-3851, 12/2016, Volume 36, Issue 13, pp. 1211 - 1216
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2014, Volume 78, Issue 4, pp. 877 - 885
Journal Article